Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
Open Access
- 15 February 2012
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 307 (7), 674-684
- https://doi.org/10.1001/jama.2012.120
Abstract
Although primarily recommended for improving bone health, treatment with vitamin D recently has been suggested for other conditions, including cardiovascular disease (CVD).1-3 Multiple lines of evidence suggest a link between vitamin D and CVD, including experimental studies identifying vitamin D receptors in vascular smooth muscle, endothelial cells, and possibly cardiac tissue1,4 and observational studies, small clinical trials, and meta-analyses suggesting that vitamin D therapy reduces cardiovascular events.2,3 Convincing data demonstrating that vitamin D therapy improves cardiovascular health, however, are lacking.Keywords
This publication has 53 references indexed in Scilit:
- Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patientsEuropean Heart Journal, 2010
- Endocrine functions of bone in mineral metabolism regulationJCI Insight, 2008
- Activated vitamin D sterols in kidney diseaseThe Lancet, 2008
- Vitamin D Deficiency and Risk of Cardiovascular DiseaseCirculation, 2008
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006
- Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKDAmerican Journal of Kidney Diseases, 2005
- Activated Injectable Vitamin D and Hemodialysis SurvivalJournal of the American Society of Nephrology, 2005
- Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol TherapyThe New England Journal of Medicine, 2003
- 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes.JCI Insight, 1996